breseq  version 0.35.4  revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Marginal read alignment evidence (highest frequency 20 of 193 shown, sorted by frequency from high to low)
  seq id position ref new freq score (cons/poly) reads annotation genes product
*NZ_CP0092734,245,9970GC44.3% 89.8 / 29.7 61P133R (CCG→CGG) plsBglycerol‑3‑phosphate 1‑O‑acyltransferase PlsB
*NZ_CP0092734,570,4510CT42.9% 97.9 / 30.3 70E277K (GAA→AAA) hsdStype I restriction‑modification system specificity subunit
*NZ_CP0092733,199,7940CT41.3% 39.3 / 57.5 75intergenic (‑179/‑28)ttdR/ttdADNA‑binding transcriptional activator TtdR/L(+)‑tartrate dehydratase subunit alpha
*NZ_CP0092732,221,7570GC39.0% 60.5 / 13.3 41pseudogene (481/1436 nt)mdtQmultidrug resistance outer membrane protein MdtQ
*NZ_CP0092732,380,3410GA37.5% 73.1 / 35.9 56intergenic (+31/‑72)yfbL/yfbMM28 family metallopeptidase/YfbM family protein
*NZ_CP0092732,221,7680TC36.6% 59.0 / 10.3 41pseudogene (470/1436 nt)mdtQmultidrug resistance outer membrane protein MdtQ
*NZ_CP0092733,855,9980TC36.2% 68.9 / 17.1 48pseudogene (966/1617 nt)BW25113_RS19145PTS sugar transporter subunit IIB
*NZ_CP009273595,0320TG36.1% 112.9 / 21.2 61V288G (GTG→GGG) cusACu(+)/Ag(+) efflux RND transporter permease subunit CusA
*NZ_CP0092732,178,6780TG36.0% 131.9 / 22.2 75T35P (ACC→CCC) thiMhydroxyethylthiazole kinase
*NZ_CP0092733,578,4460AC35.4% 150.7 / 26.3 79Y580D (TAC→GAC) ggtgamma‑glutamyltransferase
*NZ_CP0092733,659,0620CA35.2% 149.6 / 33.4 88A37S (GCG→TCG) gadXacid resistance transcriptional activator GadX
*NZ_CP0092733,524,7990AC34.7% 206.8 / 20.6 98Y334D (TAT→GAT) yhgEDUF4153 domain‑containing protein
*NZ_CP009273328,7110AG34.4% 111.2 / 17.3 64G210G (GGA→GGGpdeLDNA‑binding transcriptional activator/c‑di‑GMP phosphodiesterase PdeL
*NZ_CP0092733,394,8180TC34.3% 136.8 / 13.8 70D625G (GAT→GGT) csrDRNase E specificity factor CsrD
*NZ_CP009273748,5810TA34.2% 157.5 / 25.0 79intergenic (‑330/+60)ybgD/gltAfimbrial protein/citrate synthase
*NZ_CP0092732,621,9790TA33.9% 97.8 / 19.4 62T107S (ACT→TCT) pdeFcyclic‑guanylate‑specific phosphodiesterase PdeF
*NZ_CP0092734,612,0670AG33.9% 118.4 / 18.5 65E161G (GAG→GGG) yjjJtype II toxin‑antitoxin system HipA family toxin YjjJ
*NZ_CP00927329,4860CA33.3% 139.6 / 23.9 66intergenic (+291/‑165)dapB/carA4‑hydroxy‑tetrahydrodipicolinate reductase/glutamine‑hydrolyzing carbamoyl‑phosphate synthase small subunit
*NZ_CP0092731,240,6900GT33.3% 123.9 / 18.4 63L25F (TTG→TTTBW25113_RS06225protein YcgY
*NZ_CP0092731,652,4240GT33.3% 114.3 / 16.6 72L33F (TTG→TTTynfEDmsA/YnfE/YnfF family dimethyl sulfoxide reductase

Marginal new junction evidence (sorted from low to high skew)
  seq id position reads (cov) reads (cov) score skew freq annotation gene product
* ? NZ_CP009273 1203246 =70 (0.900)22 (0.300) 21/464 5.3 26.6% coding (290/630 nt) BW25113_RS05990 protein StfP
?NZ_CP009273 1205075 = 56 (0.770)coding (40/540 nt) BW25113_RS06005 phage tail protein
* ? NZ_CP009273 = 120326166 (0.850)20 (0.270) 20/464 5.5 25.5% coding (305/630 nt) BW25113_RS05990 protein StfP
?NZ_CP009273 = 1205058 55 (0.760)coding (57/540 nt) BW25113_RS06005 phage tail protein